Evaluation of patient organ doses from kilovoltage cone-beam CT imaging in radiation therapy
Abstract
BACKGROUND: Currently, CBCT system is an indispensable component of radiation therapy units. Because of that, it is important in treatment planning and diagnosis. CBCT is also an crucial tool for patient positioning and verification in image-guided radiation therapy (IGRT). Therefore, it is critical to investigate the patient organ doses arising from CBCT imaging. The purpose of this study is to evaluate patient organ doses and effective dose to patients from three different protocols of Elekta Synergy XVI system for kV CBCT imaging examinations in image guided radiation therapy.
MATERIALS AND METHODS: Organ dose measurements were done with thermoluminescent dosimeters in Alderson RANDO male phantom for head & neck (H&N), chest and pelvis protocols of the Elekta Synergy XVI kV CBCT system. From the measured organ dose, effective dose to patients were calculated according to the International Commission on Radiological Protection 103 report recommendations.
RESULTS: For H&N, chest and pelvis scans, the organ doses were in the range of 0.03–3.43 mGy, 6.04–22.94 mGy and 2.5–25.28 mGy, respectively. The calculated effective doses were 0.25 mSv, 5.56 mSv and 4.72 mSv, respectively.
CONCLUSION: The obtained results were consistent with the most published studies in the literature. Although the doses to patient organs from the kV CBCT system were relatively low when compared with the prescribed treatment dose, the amount of delivered dose should be monitored and recorded carefully in order to avoid secondary cancer risk, especially in pediatric examinations.
Keywords: kV CBCTequivalent organ doseeffective doseimage guided radiation therapyAlderson Rando phantom
References
- Stewart BW, Wild C. 2014 World Cancer Report . International Agency for Research on Cancer, Lyon 2014.
- Xu XG, Bednarz B, Paganetti H. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol. 2008; 53(13): R193–R241.
- Jaffray DA. Emergent technologies for 3-dimensional image-guided radiation delivery. Semin Radiat Oncol. 2005; 15(3): 208–216.
- Akyalcin S, English JD, Abramovitch KM, et al. Measurement of skin dose from cone-beam computed tomography imaging. Head Face Med. 2013; 9: 28.
- Ernst M, Manser P, Dula K, et al. TLD measurements and Monte Carlo calculations of head and neck organ and effective doses for cone beam computed tomography using 3D Accuitomo 170. Dentomaxillofac Radiol. 2017; 46(7): 20170047.
- Boyer AL, Antonuk L, Fenster A, et al. A review of electronic portal imaging devices (EPIDs). Med Phys. 1992; 19(1): 1–16.
- Dzierma Y, Mikulla K, Richter P, et al. Imaging dose and secondary cancer risk in image-guided radiotherapy of pediatric patients. Radiat Oncol. 2018; 13(1): 168.
- Hess CB, Thompson HM, Benedict SH, et al. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016; 94(5): 978–992.
- Hyer DE, Serago CF, Kim S, et al. An organ and effective dose study of XVI and OBI cone-beam CT systems. J Appl Clin Med Phys. 2010; 11(2): 3183.
- Golikov VY, Nikitin VV. Estimation of the mean organ doses and the effective dose equivalent from Rando phantom measurements. Health Phys. 1989; 56(1): 111–115.
- Scalzetti EM, Huda W, Bhatt S, et al. A method to obtain mean organ doses in a RANDO phantom. Health Phys. 2008; 95(2): 241–244.
- International Commission on Radiological Protection (ICRP). The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP. 2007; 37(2–4): 1–332.
- International Commission on Radiological Protection.. 1991Recommendations of the International Commission of Radiological Protection. ICRP Publication 60. Pergamon Press, Oxford 1991.
- International Commission on Radiological Protection. Age-dependent Doses to Members of the Public from Intake of Radionuclides — Part 2 Ingestion Dose Coefficients. ICRP Publication 67. Ann. ICRP. 1997; 23(3–4).
- Huda W, Sandison GA. Estimation of mean organ doses in diagnostic radiology from Rando phantom measurements. Health Phys. 1984; 47(3): 463–467.
- Dzierma Y, Ames E, Nuesken F, et al. Image quality and dose distributions of three linac-based imaging modalities. Strahlenther Onkol. 2015; 191(4): 365–374.
- Marchant TE, Joshi KD, Moore CJ. Accuracy of radiotherapy dose calculations based on cone-beam CT: comparison of deformable registration and image correction based methods. Phys Med Biol. 2018; 63(6): 065003.
- Conrad M, Bolard G, Nowak M, et al. Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments. Z Med Phys. 2018; 28(4): 276–285.
- Ding GX, Munro P. Radiation exposure to patients from image guidance procedures and techniques to reduce the imaging dose. Radiother Oncol. 2013; 108(1): 91–98.
- Ariyaratne H, Chesham H, Pettingell J, et al. Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin. Radiother Oncol. 2016; 121(1): 103–108.
- Son K, Kim JS, Lee H, et al. Imaging dose of human organs from kV-CBCT in image-guided radiation therapy. Radiat Prot Dosimetry. 2017; 175(2): 194–200.
- Amer A, Marchant T, Sykes J, et al. Imaging doses from the Elekta Synergy X-ray cone beam CT system. Br J Radiol. 2007; 80(954): 476–482.
- Sykes JR, Amer A, Czajka J, et al. A feasibility study for image guided radiotherapy using low dose, high speed, cone beam X-ray volumetric imaging. Radiother Oncol. 2005; 77(1): 45–52.
- Moon Y, Kim HJ, Kwak D, et al. Effective dose measurement for cone beam computed tomography using glass dosimeter. Nucl Engineer Tech. 2014; 46(2): 255–262.
- Dufek V, Horakova I, Novak L. Organ and effective doses from verification techniques in image-guided radiotherapy. Radiat Prot Dosimetry. 2011; 147(1-2): 277–280.